share_log
Reuters ·  Apr 30 12:12
Eli Lilly:Proposed US Biosecure Act Would Affect Pharmaceutical Supply Chain Elements;Currently Do Not See It to Have Material Impact on Business
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment